Targeting Cancer Metabolism as a New Strategy to Enhance Treatment Efficacy and Overcome Resistance

被引：0
|
作者：
Tucci, Paola [1 ]
机构：
[1] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy
来源：
CANCERS | 2024年 / 16卷 / 21期
关键词：
CELL; SERINE;
D O I：
10.3390/cancers16213629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance
    Lanzi, Cinzia
    Zaffaroni, Nadia
    Cassinelli, Giuliana
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (26) : 2860 - 2886
  • [22] Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
    Veiga, Rafaela Nasser
    de Azevedo, Alexandre Luiz Korte
    de Oliveira, Jaqueline Carvalho
    Gradia, Daniela Fiori
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2024, 102 (04): : 479 - 493
  • [23] Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
    Rafaela Nasser Veiga
    Alexandre Luiz Korte de Azevedo
    Jaqueline Carvalho de Oliveira
    Daniela Fiori Gradia
    Journal of Molecular Medicine, 2024, 102 : 479 - 493
  • [24] Targeting the mevalonate pathway in HER2+breast cancer to overcome resistance and enhance anti-HER2 therapy efficacy
    Sethunath, Vidyalakshmi
    Hu, Huizhong
    DeAngelis, Carmine
    Veeraraghavan, Jamunarani
    Qin, Lanfang
    Shea, Martin
    Mitchell, Tamika
    Nanda, Sarmistha
    Pereira, Resel
    Hilsenbeck, Susan G.
    Rimawi, Mothaffar F.
    Osborne, Kent C.
    Schiff, Rachel
    CANCER RESEARCH, 2019, 79 (13)
  • [25] New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistance
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2012, 38 (04) : 303 - 310
  • [26] Targeting Metabolism of Ovarian Cancer as New Therapeutic Strategy.
    Kudo, Kei
    Ito, Kiyoshi
    Yamada, Hidekazu
    Hiroshi, Shima
    Yaegashi, Nobuo
    Tanuma, Nobuhiro
    REPRODUCTIVE SCIENCES, 2019, 26 : 340A - 340A
  • [27] Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
    Zhang, Xin
    Wang, Xuemei
    Hou, Lijian
    Xu, Zheng
    Liu, Yu'e
    Wang, Xueju
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies
    Wu, Wenda
    Xue, Xuezhen
    Chen, Yan
    Zheng, Ning
    Wang, Jichuang
    PHARMACOLOGICAL RESEARCH, 2022, 184
  • [29] Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
    Wang, Lishun
    Xu, Hanchen
    Wu, Yadi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] TARGETING TUMOR OXIDATIVE METABOLISM TO OVERCOME HYPOXIA-INDUCED IMMUNOTHERAPY RESISTANCE IN PROSTATE CANCER
    Jayaprakash, Priyamvada
    Curran, Michael
    Morrow, Brittany
    Marszalek, Joseph
    Bhanu, Krithikaa Rajkumar
    Rice, Meghan
    Gay, Jason
    Vellano, Christopher
    Cowen, Benjamin
    Welsch, Dean
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A868 - A868
12345